TATI - Tübingen Ageing and Tumour Immunology Group
The Tübingen Ageing and Tumour Immunology Group (TATI) conducts research in human immunosenescence, vaccination, tumor immunity, immunotherapy, Alzheimer disease, longevity, immunity and aging. Our expertise is in polychromatic flow cytometry, T cell cloning, confocal microscopy, proteomics, signal transduction, hypoxia, antigen identification, immune monitoring, cancer vaccination, influenza vaccination.
Recent Publications
Fülöp T, Larbi A, Extermann M, Solana R, Dupuis G, Kotb R, Derhovanassian E, Pawelec G.
Aging, Immunosenescence, and Cancer. In: Rahman I, Bagchi D (eds). Inflammation, Advancing Age and Nutrition: Research and Clinical Interventions 1edn. Academic Press, Oct 17 2013, p 55-69 [Link]
Ioannoua K, Derhovanessian E, Tsakiric E, Samaraa P, Kalbacher H, Voelter W, Trougakosc I, Pawelec G, Tsitsilonisa OE.
Prothymosin α and a prothymosin α-derived decapeptide induce ΤH1-type tumor-specific immune responses via ligating Toll-like receptor-4.
BMC Immunol. 2013 Sep 22;14(1):43 [Epub ahead of print]
Fülöp T, Larbi A, Pawelec G.
Human T cell aging and the impact of persistent viral infections.
Front Immunol. 2013 Sep 13;4:271 [PubMed]
Buffa S, Pellicanò M, Bulati M, Martorana A, Goldeck D, Caruso C, Pawelec G, Colonna-Romano G.
A novel B cell population revealed by a CD38/CD24 gating strategy: CD38(-)CD24(-) B cells in centenarian offspring and elderly people.
Age (Dordr). 2013 Oct;35(5):2009-24 [PubMed]
Alam I, Goldeck D, Larbi A, Pawelec G.
Aging affects the proportions of T and B cells in a group of elderly men in a developing country—a pilot study from Pakistan.
Age (Dordr). 2013 Oct;35(5):1521-30 [PubMed]
There is a complete list of the publication since 2012 of the TATI Group on the website.
Recent and Future Activities
June-December 2013: K. Wistuba-Hamprecht will be in Singapore with Prof. Ng Tze Pin (NUS) & Dr. Larbi (A*Star)
performing CyTOF-analysis of “immune-phenotyping studies” with unique cohorts. The CyTOF (Masscytometer) is the next generation of Cytometers and allows the observation of 35 markers in parallel. Kilians visit is part of his Ph.D thesis and granted by a scholarship of the “Baden-Württemberg Stiftung”.
Oct 2013: G. Pawelec is on the organising committee of the PIVAC 2013 Annual Meeting
October 2-4, Amsterdam, Netherlands.
Oct 2013: J. Kini & A. Martens will take part in PIVAC 2013 Annual Meeting
October 2-4, Amsterdam, Netherlands.
Oct 7, 2013: „Kiki“ Kyriaki Ioannou finishes her doctoral degree in Athens.
Oct 8, 2013: Henning Zelba and Dr. B. Weide receive the prize for the Paper of the Year
of the Medical Faculty for their publication “Weide B, Zelba H, et al.: Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis. J Clin Oncol. 2012 May 20;30(15):1835-41.
Picture (C) Martin Schreier, schreier.msc@web.de.
Oct 2013: G. Pawelec is invited speaker at the Cold Spring Harbor Asia Conferences.
The conference on Tumor Immunology and Immunotherapy takes place in Suzhou, China from October 28 to November 1, 2013.
Oct 30, 2013: Henning Zelba leaves the TATI Group
to join the Department of Immunology of the University of Tübingen.
You can find a complete list of future activites or previous activities on this website.
Print Version